Neurocrine Biosciences reported $-16900000 in Net Income for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Net Income Change
Abbvie ABBV:US $ 924M 3566M
Acadia Pharmaceuticals ACAD:US $ -113.06M 69.96M
Acorda Therapeutics ACOR:US $ -46.68M 22.16M
Agios Pharmaceuticals AGIO:US $ -91.81M 2.97M
ALKERMES ALKS:US $ -30.14M 5.77M
Alnylam Pharmaceuticals ALNY:US $ -277.4M 37.06M
Amgen AMGN:US $ 1317M 159M
Biogen BIIB:US $ 1058M 754.2M
Biomarin Pharmaceutical BMRN:US $ 27.66M 93.13M
Cytokinetics CYTK:US $ -19.82M 69.62M
Dynavax Technologies DVAX:US $ 128.76M 95.9M
Enanta Pharmaceuticals ENTA:US $ -33.59M 3.48M
Exelixis EXEL:US $ 68.57M 26.59M
Gilead Sciences GILD:US $ 1144M 1125M
Halozyme Therapeutics HALO:US $ 60.11M 6.66M
Intercept Pharmaceuticals ICPT:US $ -7.53M 9.76M
Intra Cellular Therapies ITCI:US $ -72.12M 13.62M
IONIS PHARMACEUT IONS:US $ -65.17M 289.78M
Nektar Therapeutics NKTR:US $ -159.07M 68.68M
Neurocrine Biosciences NBIX:US $ -16.9M 30.8M
Pfizer PFE:US $ 9905M 2042M
Prothena PRTA:US $ -36.29M 3.11M
Regeneron Pharmaceuticals REGN:US $ 852.1M 121.4M
Repligen RGEN:US $ 49.86M 2.9M
Rigel Pharmaceuticals RIGL:US $ -13.49M 13.95M
Sarepta Therapeutics SRPT:US $ -231.48M 126.46M
Teva Pharmaceutical TEVA:IT -233000000 722M
Ultragenyx Pharmaceutical RARE:US $ -158.16M 5.84M
Vertex Pharmaceuticals VRTX:US $ 810.5M 48.4M
Xoma XOMA:US $ -4670000 2.39M
YTE INCY:US $ 161.43M 123.44M